BDBM224086 3-(6-(3- chlorophenyl)-8- (((s)-1-hydroxy-2- phenylpropan-2- yl)amino)-7-(((trans)- 4- methylcyclohexyl) methyl)-7h-purin-2-yl)- 1,2,4-oxadiazol- 5(4h)-one::US9540377, 16.5

SMILES C[C@@](CO)(Nc1nc2nc(-c3noc(=O)[nH]3)nc(-c3cccc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)c1ccccc1

InChI Key InChIKey=SVMLACNQIJTXAA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224086   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224086BDBM224086(US9540377, 16.5 | 3-(6-(3- chlorophenyl)-8- (((s)-...)
Affinity DataIC50: 1.59nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent